{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:40:05Z","timestamp":1783658405464,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ijcard.2019.12.069","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T08:20:50Z","timestamp":1578385250000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The association between renin angiotensin aldosterone system blockers and future osteoporotic fractures in a hypertensive population \u2013 A population-based cohort study in Taiwan"],"prefix":"10.1016","volume":"305","author":[{"given":"Yung-Ta","family":"Kao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ann","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Chi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.12.069_bb0005","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.injury.2010.05.025","article-title":"Estimated prevalence of orthopaedic fractures in Taiwan-a cross-sectional study based on nationwide insurance data","volume":"41","author":"Yang","year":"2010","journal-title":"Injury."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0015","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.1994.03520240037038","article-title":"Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial","volume":"272","author":"Nelson","year":"1994","journal-title":"JAMA."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0020","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2265.1989.tb00443.x","article-title":"Nasal calcitonin for treatment of established osteoporosis","volume":"30","author":"Overgaard","year":"1989","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0030","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","article-title":"Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese","volume":"38","author":"Lynn","year":"2006","journal-title":"Bone."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0035","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.1097\/MD.0000000000008331","article-title":"Association between renin-angiotensin-aldosterone system blockade and future osteoporotic fracture risk in hypertensive population: a population-based cohort study in Taiwan","volume":"96","author":"Chen","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijcard.2019.12.069_bb0040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10654-017-0285-4","article-title":"Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies","volume":"32","author":"Kunutsor","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0045","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s12020-016-1201-5","article-title":"ACE inhibitors and the risk of fractures: A meta-analysis of observational studies","volume":"55","author":"Cheng","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ijcard.2019.12.069_bb0050","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MD.0000000000000462","article-title":"Cancer risk in HBV patients with statin and metformin use: a population-based cohort study","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijcard.2019.12.069_bb0055","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1097\/MD.0000000000002868","article-title":"Influenza vaccination reduces dementia risk in chronic kidney disease patients: a population-based cohort study","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijcard.2019.12.069_bb0060","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.parkreldis.2012.03.010","article-title":"Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson\u2019s disease occurring with type 2 diabetes in a Taiwanese population cohort","volume":"18","author":"Wahlqvist","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0065","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0070","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/pds.1062","article-title":"An application of propensity score matching using claims data","volume":"14","author":"Seeger","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0090","series-title":"ATC Index With DDDs 2003","year":"2003"},{"key":"10.1016\/j.ijcard.2019.12.069_bb0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.1200","article-title":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics","volume":"15","author":"Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1359\/jbmr.081006","article-title":"Activation of renin-angiotensin system induces osteoporosis independently of hypertension","volume":"24","author":"Asaba","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0110","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jcp.20944","article-title":"Low-intensity pulsed ultrasound (LIPUS) induces RANKL, MCP-1, and MIP-1beta expression in osteoblasts through the angiotensin II type 1 receptor","volume":"211","author":"Bandow","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1677\/joe.0.1560543","article-title":"Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells","volume":"156","author":"Hagiwara","year":"1998","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0120","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1074\/jbc.M807610200","article-title":"Angiotensin II type 2 receptor blockade increases bone mass","volume":"284","author":"Izu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0125","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1096\/fj.07-098954","article-title":"Angiotensin II accelerates osteoporosis by activating osteoclasts","volume":"22","author":"Shimizu","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0130","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1271\/bbb.120123","article-title":"Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing mice","volume":"76","author":"Gu","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0135","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","article-title":"Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese","volume":"38","author":"Lynn","year":"2006","journal-title":"Bone."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0140","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","article-title":"Treatment with beta-blockers, ACEI inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study","volume":"24","author":"Rejnmark","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0145","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00198-011-1831-7","article-title":"Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men?","volume":"23","author":"Kwok","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12877-015-0154-5","article-title":"Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study","volume":"15","author":"Ruths","year":"2015","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.ijcard.2019.12.069_bb0155","first-page":"57","article-title":"Osteoporotic fractures in men (MrOS) research group. ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men","volume":"46","author":"Kwok","year":"2017","journal-title":"Age Ageing"},{"key":"10.1016\/j.ijcard.2019.12.069_bb0160","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.356","article-title":"Risk of fractures in older adults using antihypertensive medications","volume":"26","author":"Solomon","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"Pt 2","key":"10.1016\/j.ijcard.2019.12.069_bb0170","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/bj3280701","article-title":"Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells","volume":"328","author":"Aubert","year":"1997","journal-title":"Biochem. J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319324714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319324714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:46:02Z","timestamp":1759092362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319324714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":33,"alternative-id":["S0167527319324714"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.12.069","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between renin angiotensin aldosterone system blockers and future osteoporotic fractures in a hypertensive population \u2013 A population-based cohort study in Taiwan","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.12.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}